On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Stocks To Buy Now

Blog


SRAX Inc.’s (NASDAQ: SRAX) Sequire Offers Key Data Management, Analytics as Companies Look for Valuable Expertise, Insight

  • NASDAQ article reports verticalization, specialization of data and analytics platforms will take on growing importance in coming year
  • Sequire platform offers new level of domain expertise, knowledge
  • Since its launch, Sequire has gained more than 1 million active investors, traders from 91 public companies
A recent NASDAQ article noting the top 10 data analytics trends for 2021 reported that the verticalization and specialization of data and analytics platforms will take on growing importance in the new year (https://ibn.fm/irU4C). SRAX (NASDAQ: SRAX), a digital marketing and consumer data-management technology company, appears to be ideally positioned to thrive within those expectations. “The need for analytics is well-established, and generic platforms that crunch data and create visualizations have matured,” reported the NASDAQ article, which was titled “What Data Analytics Will Look Like in 2021 — And How to Capitalize On It.” The article continued, noting that “enterprises will now expect a level of domain expertise and knowledge of how data and analytics can support specific use cases, and thus will gravitate towards platforms that can meet their needs more specifically with capabilities such as risk modeling for insurance, or in the case of Signals Analytics, marketing intelligence to support the product life cycles. With 80% of analytics projects failing, this will be one way that companies will be able to buck the trend.” Domain expertise and knowledge is at the core of Sequire, an investor intelligence and communications platform created by SRAX in 2019. Sequire gathers and analyzes data about stock buyers’ behaviors and trends for issuers of publicly traded companies, allowing those issuers to use audience insights to capture the interest of existing investors and attract new ones. Since its launch, Sequire has gained more than 1 million active investors and traders from 91 public companies (https://ibn.fm/eSG5s). Originally called SRAX IR, the data-management platform was renamed Sequire because that name better represents the platform’s main objective of gathering, managing and analyzing data to acquire and secure investors for publicly traded companies (https://ibn.fm/71Mus). Sequire’s intelligent technologies distinguish it from other offerings in the world of data collection and reinforce the company’s focus on innovation and uniqueness in the marketplace (https://ibn.fm/51XDL). SRAX is dedicated to building the largest and most reliable opted-in data sets across many industry verticals; accurately identifying target consumers for brands and companies in the CPG, investor relations, luxury, and lifestyle spaces; and keeping those brands ahead in the competitive curve with high-quality data. The Company also provides other verticals, including SRAX Core, a custom digital media-management platform that enables brands and agencies to surpass the challenges of omnichannel marketing campaigns; SRAX Social, a free social media management tool that makes it easy for brands, agencies and individuals to grow their digital presence; SRAX Auto, which unlocks auto intenders’ data to create measurable connected experiences on the road to purchase; SRAX Shopper, which delivers a cross-channel, premium digital experience at scale to high-value shopper audiences; and SRAX Lux, which targets and reaches consumers at luxury retail stores as well as high-end art, music, film, fashion and sports events, across all consumer devices. For more information about SRAX and Sequire, visit the companies’ websites at www.SRAX.com and www.MySequire.com. NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

From Our Blog

Longeveron Inc. (NASDAQ: LGVN) Discusses 2023 Progress and 2024 Plans in Corporate Update

March 28, 2024

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing regenerative medicine for life-threatening conditions with unmet medical needs, recently released its full-year results for the period ended December 31, 2023, and provided a corporate update (https://ibn.fm/iORBu). Results from multiple studies using Longeveron’s lead investigational therapeutic candidate, Lomecel-B(TM), were announced by the company last year. “In 2023 […]

Rotate your device 90° to view site.